These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36460881)
21. Natural killer T cell activation increases iNOS Paul S; Chhatar S; Mishra A; Lal G J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637 [TBL] [Abstract][Full Text] [Related]
22. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792 [TBL] [Abstract][Full Text] [Related]
23. In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses. Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA Dev Comp Immunol; 2015 Mar; 49(1):49-58. PubMed ID: 25445911 [TBL] [Abstract][Full Text] [Related]
24. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288 [TBL] [Abstract][Full Text] [Related]
25. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281 [TBL] [Abstract][Full Text] [Related]
26. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus. Godó M; Sessler T; Hamar P Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038 [TBL] [Abstract][Full Text] [Related]
28. Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer. Gebremeskel S; Lobert L; Tanner K; Walker B; Oliphant T; Clarke LE; Dellaire G; Johnston B Cancer Immunol Res; 2017 Dec; 5(12):1086-1097. PubMed ID: 29054890 [TBL] [Abstract][Full Text] [Related]
29. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. Tulley JM; Palmer JL; Gamelli RL; Faunce DE Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934 [TBL] [Abstract][Full Text] [Related]
30. Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells. Fujii S; Shimizu K; Steinman RM; Dhodapkar MV J Immunol Methods; 2003 Jan; 272(1-2):147-59. PubMed ID: 12505720 [TBL] [Abstract][Full Text] [Related]
31. Tissue-Specific Roles of NKT Cells in Tumor Immunity. Terabe M; Berzofsky JA Front Immunol; 2018; 9():1838. PubMed ID: 30158927 [TBL] [Abstract][Full Text] [Related]
32. Reconstitution models to evaluate natural killer T cell function in tumor control. Gebremeskel S; Slauenwhite D; Johnston B Immunol Cell Biol; 2016 Jan; 94(1):90-100. PubMed ID: 26095148 [TBL] [Abstract][Full Text] [Related]
33. Role of γδ T cells in α-galactosylceramide-mediated immunity. Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194 [TBL] [Abstract][Full Text] [Related]